Update interpretation of DrugBank actions

[cthoyt]

This PR closes #1263 by updating some of the interpretations made in DrugBank's action field.

It's most likely the case that all curated interactions in DrugBank imply binding between an active molecule and the target. For example, some actions like agonist, partial agonist, antagonist, partial antagonist, and inverse agonist do not give enough information to infer activates or inhibits, because they are with respect to the native ligand. Therefore, the best we can do is say that these chemicals bind to their targets (in the absence a more generic INDRA Statement for apolar regulates activity).

This PR also does the following:

• adds several interpretations that were missing
• reorganizes the order of priority of mapping to statement types
• small style updates in the DrugBank processor code

Statistics

Before

Action	Count
Inhibition	16,026
Activation	2,569
DecreaseAmount	69
IncreaseAmount	8

After

Statement Type	Count
Inhibition	5,012
Activation	2,088
Complex	1,325
DecreaseAmount	73
IncreaseAmount	27

[cthoyt]

Binder and binding both are neutral, but most antibodies that I know of exert their action by binding to a protein, which either tags it for degradation or inhibits it. I think leaving as inhibits is fine.

[bgyori]

It turns out that there is a large number of entries that neither specify an action, nor declare that there is a direct interaction between the drug and the target. Since it's not clear what statement type these can be mapped to if we want to be precise, we skip them now. The statement count drops significantly, with the overall statement stats before this PR:

('Inhibition', 16026),
('Activation', 2569),
('DecreaseAmount', 69),
('IncreaseAmount', 8)

and after this PR

('Complex', 4320),
('Inhibition', 3121),
('Activation', 724),
('DecreaseAmount', 60),
('IncreaseAmount', 28)